Showing results (11-20 of 41) with videos related to
Sort By:
Pageof 5
Dental Materials Journal|May 21, 2011
The influence of light intensities irradiated directly and indirectly through resin composite to self-etch adhesives on dentin bondingNaoko Seki, Masatoshi Nakajima, Ryuzo Kishikawa, et al.Clinical Endocrinology|August 11, 2017
A polymorphism of the 5' flanking region of tumour necrosis factor α gene is associated with thyroid-associated ophthalmopathy in JapaneseShintaro Kamizono, Yuji Hiromatsu, Naoko Seki, et al.Journal of Dental Sciences|July 14, 2025
A study of critical thinking skills among Thai dental students: From disposition to skills assessmentKittichai Sireerat, Naoko Seki, Richard Foxton, et al.Journal of Medical and Dental Sciences|May 17, 2016
Evaluation of simulation learning materials use to fill the gap in Japanese dental English educationNaoko Seki, Janelle Moross, Masayo Sunaga, et al.Journal of Dental Sciences|October 27, 2022
Effects of two-year oral health information provision on changes in gingival crevicular fluid in male day-night shift workersMio Naito, Kayoko Shinada, Naoko Seki, et al.International Journal of Oncology|December 10, 2015
CD44v3+/CD24- cells possess cancer stem cell-like properties in human oral squamous cell carcinomaKeita Todoroki, Sachiko Ogasawara, Jun Akiba, et al.Future Oncology (London, England)|March 17, 2009
YB-1 prevents apoptosis via the mTOR/STAT3 pathway in HER-2-overexpressing breast cancer cellsTeruhiko Fujii, Naoko Seki, Roka Namoto-Matsubayashi, et al.Journal of Dental Sciences|January 14, 2022
Evaluating e-learning on an international scale: An audit of computer simulation learning materials in the field of dentistryAi Ohsato, Naoko Seki, Tam Thi Thanh Nguyen, et al.Oncology Letters|January 22, 2024
Prognostic effect of programmed cell death ligand 1/programmed cell death 1 expression in cancer stem cells of human oral squamous cell carcinomaKeita Todoroki, Yushi Abe, Katsuhisa Matsuo, et al.Journal of Stomatology, Oral and Maxillofacial Surgery|July 3, 2024
What prognostic factors have impacted the efficacy of immune checkpoint inhibitors in patients with recurrent or metastatic oral cancer?Shogo Kikuta, Yushi Abe, Kiyosato Hino, et al.Pageof 5